PALMELLE
 Read · Health Policy
Medicare's 'Healthcare' Pivot: More Cash for Insurers, Not Necessarily You
Health Policy

Medicare's 'Healthcare' Pivot: More Cash for Insurers, Not Necessarily You

CMS proposes 2027 reforms, promising value-based care while boosting Medicare Advantage payments.

By Neil D'Monte, Palmelle Editorial Team · Reviewed by Neil D'Monte · 7 min read · 2026-07-16
SHORT ANSWER
CMS is proposing 2027 Medicare reforms to focus on 'healthcare' over 'sick care,' but this includes a projected 2.48% increase in payments to Medicare Advantage plans, injecting billions into insurers.

The direct answer

The Centers for Medicare & Medicaid Services (CMS) is proposing significant changes for 2027 aimed at shifting Medicare from a 'sick care' model to a 'healthcare' approach, emphasizing preventive services and value-based payments

. A key component involves substantial increases in payments to Medicare Advantage (MA) plans. For 2027, CMS finalized policies projecting a net average increase of 2.48% for MA payments, translating to over $13 billion in additional funds for these private insurers

. This move is seen as a direct financial boost to major MA players like UnitedHealth Group ($UNH), Humana ($HUM), and CVS Health ($CVS) [c2, c3, c4]. The agency will also maintain the 2024 MA risk adjustment model, excluding most unlinked chart review diagnoses from its calculations

. While framed as a modernization, the substantial infusion of cash into MA plans raises questions about whether this translates to better direct care or more profit for insurers.

The 'Value-Based Care' Paradox

CMS's stated aim is to transition Medicare towards value-based care, a system where providers are reimbursed based on patient health outcomes rather than the volume of services provided. This sounds like a win for everyone, especially seniors who could benefit from more coordinated and preventive care. However, the immediate financial impact of the proposed 2027 changes appears to be a significant boost to Medicare Advantage plans, which are already private entities administering the government program. The projected 2.48% increase in MA payments

, which was higher than many analysts anticipated

, means billions more flowing into the coffers of companies like UnitedHealth Group. The question becomes: how much of this increased reimbursement will translate into tangible improvements in care quality and accessibility for beneficiaries versus enhanced insurer profits?

Risk Adjustment: A Move to Keep the Status Quo?

A critical, though less headline-grabbing, aspect of the CMS proposal is the decision to maintain the 2024 Medicare Advantage risk adjustment model for 2027. This model, which determines how much Medicare pays MA plans based on the health status of their enrollees, will exclude most diagnoses derived from unlinked chart reviews

. For years, the industry has debated the accuracy and fairness of these models. By keeping the current system, CMS signals a degree of stability, but it also means the ongoing debate about whether MA plans are adequately capturing the true health needs of their members without resorting to potentially problematic 'upcoding' or extensive, costly chart reviews continues. This decision avoids potentially disruptive changes for insurers while maintaining the existing payment structure.

Market Reaction: What Wall Street Knows

The financial markets reacted swiftly and positively to the CMS announcement regarding Medicare Advantage payments. UnitedHealth Group ($UNH) saw a significant surge in after-hours trading following the news that CMS finalized 2027 MA payment policies with a better-than-expected 2.48% increase [c3, c4]. This demonstrates that investors and analysts closely watch these regulatory decisions, viewing them as direct indicators of future profitability for health insurance giants. The inclusion of specific stock tickers like $UNH, $HUM, $CVS, and $ELV in analyses

highlights how intertwined these policy shifts are with the financial performance of major healthcare corporations. This market response underscores the substantial financial stakes involved in Medicare's operational and payment structures.

Common mistakes

PALMELLE'S VIEW
In our view, the conventional narrative framing CMS's 2027 proposals as a noble shift toward 'healthcare' conveniently glosses over the immediate financial windfall for Medicare Advantage insurers. While the stated goal of moving from 'sick care' to 'healthcare' is laudable, the projected 2.48% payment increase for MA plans

– amounting to over $13 billion – is a far more concrete and immediate outcome. This isn't just a tweak; it's a significant cash injection

that benefits publicly traded companies like $UNH and $HUM [c3, c4]. We must ask if this ‘modernization’ truly prioritizes patient well-being or simply rewards the private entities managing the program with more taxpayer dollars.

BOTTOM LINE
Ask your Medicare Advantage plan provider how the projected 2.48% payment increase for 2027 will translate into enhanced benefits or direct care improvements for you.
WHEN THIS CHANGES
The answer to how these reforms will impact beneficiaries and providers could change significantly if CMS revises the proposed payment rates, alters the risk adjustment model substantially, or if subsequent analyses reveal a disproportionate allocation of increased funds towards insurer profits rather than direct patient care enhancements.

Frequently asked

What is the main goal of CMS's proposed 2027 Medicare reforms?

The primary goal is to shift Medicare from a 'sick care' model focused on treating illness to a 'healthcare' model emphasizing preventive services, chronic disease management, and value-based payments, where providers are rewarded for patient outcomes.

How will these reforms affect Medicare Advantage plans?

CMS has finalized policies projecting a net average increase of 2.48% in payments to Medicare Advantage plans for 2027, amounting to over $13 billion. This is expected to provide a significant financial boost to these private insurers.

Will these changes mean better care for seniors?

The intention is for reforms to lead to better preventive and coordinated care. However, the substantial increase in MA payments raises questions about how much of that funding will directly benefit beneficiaries versus increasing insurer profits.

Sources

  1. Wall St Engine (X Post)
  2. Casey | Trade Tracs (X Post)
  3. TrendSpider (X Post)
  4. Stocker-Man (X Post)

Keep reading

Health PolicyDOJ Policy Shift and Medicaid Cuts Threaten Home-Based Care for Frail SeniorsHealth PolicyMedicare's $50 GLP-1 Bridge: The Unexpected Lifeline for Senior Weight-Loss DrugsHealth PolicyMedicare Advantage 2027: CMS Offers Gifts to Insurers, Pockets for SeniorsHealth PolicyPharma's Lobbying Blitz: How Drug Giants Are Rewriting Medicare Rules for ProfitHealth PolicyCMS Throws Home Health a Lifeline, Not Just a Budget AxeHealth PolicyMedicare's New $50 Weight-Loss Drug Deal: More Than Just a Bridge

More from Health Policy →   ·   Back to Perch   ·   Browse all stories